ScoreWhy is Kobo Biotech Ltd ?
1
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Poor long term growth as Net Sales has grown by an annual rate of -100.00% and Operating profit at 0% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 0 times
2
Flat results in Jun 24
- OPERATING PROFIT(Q) Lowest at INR -3.42 MM
- PRE-TAX PROFIT(Q) Lowest at INR -13.29 MM
- NET PROFIT(Q) Lowest at INR -13.29 MM
3
Risky - No result in last 6 months
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -22.84%, its profits have risen by 11%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -22.84% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Commodity Chemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Kobo Biotech for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Kobo Biotech
-22.84%
-0.32
71.20%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
6.52%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.05
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.66%
ROCE (avg)
-42.40%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
40
Price to Book Value
-0.04
EV to EBIT
-29.36
EV to EBITDA
-145.01
EV to Capital Employed
21.97
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-74.85%
ROE (Latest)
Negative BV
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Loading Valuation Snapshot...
Here's what is working for Kobo Biotech
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Kobo Biotech
Operating Profit
Lowest at INR -3.42 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (INR MM)
Pre-Tax Profit
Lowest at INR -13.29 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (INR MM)
Net Profit
Lowest at INR -13.29 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (INR MM)
EPS
Lowest at INR -0.56
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (INR)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
